These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4370508)

  • 1. The use of conjugated oestrogen in oral contraception.
    Widholm O; Kaivola S; Timonen S
    Ann Chir Gynaecol Fenn; 1974; 63(3):180-5. PubMed ID: 4370508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of conjugated oestrogen upon gonadotrophin excretion patterns in fetile women.
    Kaivola S; Widholm O; Timonen S
    Ann Chir Gynaecol Fenn; 1968; 57(5):596-602. PubMed ID: 4307478
    [No Abstract]   [Full Text] [Related]  

  • 3. Low dosage megestrol acetate application as contraceptive.
    Balin H; Wan LS
    J Reprod Med; 1970 Jul; 5(1):41-8. PubMed ID: 5521770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH; Speroff L; Ellman H; Dart C
    Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical use of me-quingestanol contraceptive pill (author's transl)].
    Zhonghua Fu Chan Ke Za Zhi; 1979 Apr; 14(2):68-72. PubMed ID: 263035
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of contraceptive effect of low progestin doses].
    Korkhov VV; Makusheva VP; Nikitin AI
    Vopr Okhr Materin Det; 1977 Aug; 22(8):89-90. PubMed ID: 930034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relief of hot flushes with new plant-derived 10-component synthetic conjugated estrogens.
    Utian WH; Lederman SA; Williams BM; Vega RY; Koltun WD; Leonard TW
    Obstet Gynecol; 2004 Feb; 103(2):245-53. PubMed ID: 14754691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
    Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
    J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogens and the menopausal patient.
    Med Lett Drugs Ther; 1973 Jan; 15(2):6-8. PubMed ID: 4348858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovulation inhibitors in climacteric].
    Lauritzen C
    Dtsch Med Wochenschr; 1977 May; 102(21):812-3. PubMed ID: 194763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of small doses of megestrol acetate on the cervical mucus.
    Lebech PE; Svendsen PA; Ostergaard E
    Int J Fertil; 1970; 15(2):65-76. PubMed ID: 5464328
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: a double-blind, randomised, dose-finding pilot study.
    Chabbert-Buffet N; Chassard D; Ochsenbein E; Thomas JL; Christin-Maitre S
    Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):76-84. PubMed ID: 21332383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.